APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI In Clinical Trials

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global AI In Clinical Trials Industry Growth and Trends Forecast to 2032

5 March 2026121 pages

Choose your research edition.

Industry ResearchAI In Clinical Trials Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal AI In Clinical Trials Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal AI In Clinical Trials Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI In Clinical Trials Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal AI In Clinical Trials Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

According to APO Research, the global AI In Clinical Trials market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for AI In Clinical Trials is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for AI In Clinical Trials is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI In Clinical Trials is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the AI In Clinical Trials market include Intel, The International Business Machines Corporation(IBM), Koninklijke Philips N.V., ConcertAl, Saama Technologies LLC, Samaa Technologies, Owkin Inc., Numerate and Neuroute, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global AI In Clinical Trials market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The AI In Clinical Trials market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global AI In Clinical Trials market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to AI In Clinical Trials.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global AI In Clinical Trials market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

AI In Clinical Trials Market by Company

Intel

The International Business Machines Corporation(IBM)

Koninklijke Philips N.V.

ConcertAl

Saama Technologies LLC

Samaa Technologies

Owkin Inc.

Numerate

Neuroute

AiCure

Ardigen

Unlearn Al

PathAl

Exscentia

Aitia Infotech Pvt Ltd.

Euretos

VeriSIM Life

Envisagenics

NURITAs

BioSymetrics

BioAge Labs lInc

AI In Clinical Trials Segment by Type

Software

Service

AI In Clinical Trials Segment by Application

Pharmaceutical and Biotechnology Companies

Contract Research Organization

Other

AI In Clinical Trials Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI In Clinical Trials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI In Clinical Trials and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI In Clinical Trials.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of AI In Clinical Trials companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global AI In Clinical Trials Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global AI In Clinical Trials Market Size by Region (2021-2026) & (US$ Million) Table 3. Global AI In Clinical Trials Market Share by Region (2021-2026) Table 4. Global AI In Clinical Trials Market Size by Region (2027-2032) & (US$ Million) Table 5. Global AI In Clinical Trials Market Share by Region (2027-2032) Table 6. Global AI In Clinical Trials Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global AI In Clinical Trials Market Size by Type (2021-2026) & (US$ Million) Table 8. Global AI In Clinical Trials Market Size Share by Type (2021-2026) Table 9. Global AI In Clinical Trials Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global AI In Clinical Trials Market Size Share Forecasted by Type (2027-2032) Table 11. North America AI In Clinical Trials Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America AI In Clinical Trials Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe AI In Clinical Trials Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe AI In Clinical Trials Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific AI In Clinical Trials Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific AI In Clinical Trials Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America AI In Clinical Trials Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America AI In Clinical Trials Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa AI In Clinical Trials Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa AI In Clinical Trials Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global AI In Clinical Trials Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global AI In Clinical Trials Market Size by Application (2021-2026) & (US$ Million) Table 23. Global AI In Clinical Trials Market Size Share by Application (2021-2026) Table 24. Global AI In Clinical Trials Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global AI In Clinical Trials Market Size Share Forecasted by Application (2027-2032) Table 26. North America AI In Clinical Trials Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America AI In Clinical Trials Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe AI In Clinical Trials Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe AI In Clinical Trials Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific AI In Clinical Trials Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific AI In Clinical Trials Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America AI In Clinical Trials Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America AI In Clinical Trials Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa AI In Clinical Trials Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa AI In Clinical Trials Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. AI In Clinical Trials Industry Trends Table 37. AI In Clinical Trials Industry Drivers Table 38. AI In Clinical Trials Industry Opportunities and Challenges Table 39. AI In Clinical Trials Industry Restraints Table 40. Global AI In Clinical Trials Revenue by Company (US$ Million) & (2021-2026) Table 41. Global AI In Clinical Trials Revenue Market Share by Company (2021-2026) Table 42. Global AI In Clinical Trials Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global AI In Clinical Trials Key Company Headquarters & Area Served Table 44. Global AI In Clinical Trials Company, Product Type & Application Table 45. Global AI In Clinical Trials Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global AI In Clinical Trials by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Intel Company Information Table 49. Intel Business Overview Table 50. Intel AI In Clinical Trials Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Intel AI In Clinical Trials Product Portfolio Table 52. Intel Recent Development Table 53. The International Business Machines Corporation(IBM) Company Information Table 54. The International Business Machines Corporation(IBM) Business Overview Table 55. The International Business Machines Corporation(IBM) AI In Clinical Trials Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. The International Business Machines Corporation(IBM) AI In Clinical Trials Product Portfolio Table 57. The International Business Machines Corporation(IBM) Recent Development Table 58. Koninklijke Philips N.V. Company Information Table 59. Koninklijke Philips N.V. Business Overview Table 60. Koninklijke Philips N.V. AI In Clinical Trials Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Koninklijke Philips N.V. AI In Clinical Trials Product Portfolio Table 62. Koninklijke Philips N.V. Recent Development Table 63. ConcertAl Company Information Table 64. ConcertAl Business Overview Table 65. ConcertAl AI In Clinical Trials Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. ConcertAl AI In Clinical Trials Product Portfolio Table 67. ConcertAl Recent Development Table 68. Saama Technologies LLC Company Information Table 69. Saama Technologies LLC Business Overview Table 70. Saama Technologies LLC AI In Clinical Trials Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Saama Technologies LLC AI In Clinical Trials Product Portfolio Table 72. Saama Technologies LLC Recent Development Table 73. Samaa Technologies Company Information Table 74. Samaa Technologies Business Overview Table 75. Samaa Technologies AI In Clinical Trials Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Samaa Technologies AI In Clinical Trials Product Portfolio Table 77. Samaa Technologies Recent Development Table 78. Owkin Inc. Company Information Table 79. Owkin Inc. Business Overview Table 80. Owkin Inc. AI In Clinical Trials Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Owkin Inc. AI In Clinical Trials Product Portfolio Table 82. Owkin Inc. Recent Development Table 83. Numerate Company Information Table 84. Numerate Business Overview Table 85. Numerate AI In Clinical Trials Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Numerate AI In Clinical Trials Product Portfolio Table 87. Numerate Recent Development Table 88. Neuroute Company Information Table 89. Neuroute Business Overview Table 90. Neuroute AI In Clinical Trials Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Neuroute AI In Clinical Trials Product Portfolio Table 92. Neuroute Recent Development Table 93. AiCure Company Information Table 94. AiCure Business Overview Table 95. AiCure AI In Clinical Trials Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. AiCure AI In Clinical Trials Product Portfolio Table 97. AiCure Recent Development Table 98. Ardigen Company Information Table 99. Ardigen Business Overview Table 100. Ardigen AI In Clinical Trials Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Ardigen AI In Clinical Trials Product Portfolio Table 102. Ardigen Recent Development Table 103. Unlearn Al Company Information Table 104. Unlearn Al Business Overview Table 105. Unlearn Al AI In Clinical Trials Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Unlearn Al AI In Clinical Trials Product Portfolio Table 107. Unlearn Al Recent Development Table 108. PathAl Company Information Table 109. PathAl Business Overview Table 110. PathAl AI In Clinical Trials Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. PathAl AI In Clinical Trials Product Portfolio Table 112. PathAl Recent Development Table 113. Exscentia Company Information Table 114. Exscentia Business Overview Table 115. Exscentia AI In Clinical Trials Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Exscentia AI In Clinical Trials Product Portfolio Table 117. Exscentia Recent Development Table 118. Aitia Infotech Pvt Ltd. Company Information Table 119. Aitia Infotech Pvt Ltd. Business Overview Table 120. Aitia Infotech Pvt Ltd. AI In Clinical Trials Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Aitia Infotech Pvt Ltd. AI In Clinical Trials Product Portfolio Table 122. Aitia Infotech Pvt Ltd. Recent Development Table 123. Euretos Company Information Table 124. Euretos Business Overview Table 125. Euretos AI In Clinical Trials Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Euretos AI In Clinical Trials Product Portfolio Table 127. Euretos Recent Development Table 128. VeriSIM Life Company Information Table 129. VeriSIM Life Business Overview Table 130. VeriSIM Life AI In Clinical Trials Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. VeriSIM Life AI In Clinical Trials Product Portfolio Table 132. VeriSIM Life Recent Development Table 133. Envisagenics Company Information Table 134. Envisagenics Business Overview Table 135. Envisagenics AI In Clinical Trials Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Envisagenics AI In Clinical Trials Product Portfolio Table 137. Envisagenics Recent Development Table 138. NURITAs Company Information Table 139. NURITAs Business Overview Table 140. NURITAs AI In Clinical Trials Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. NURITAs AI In Clinical Trials Product Portfolio Table 142. NURITAs Recent Development Table 143. BioSymetrics Company Information Table 144. BioSymetrics Business Overview Table 145. BioSymetrics AI In Clinical Trials Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. BioSymetrics AI In Clinical Trials Product Portfolio Table 147. BioSymetrics Recent Development Table 148. BioAge Labs lInc Company Information Table 149. BioAge Labs lInc Business Overview Table 150. BioAge Labs lInc AI In Clinical Trials Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. BioAge Labs lInc AI In Clinical Trials Product Portfolio Table 152. BioAge Labs lInc Recent Development Table 153. North America AI In Clinical Trials Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. North America AI In Clinical Trials Market Size by Country (2021-2026) & (US$ Million) Table 155. North America AI In Clinical Trials Market Share by Country (2021-2026) Table 156. North America AI In Clinical Trials Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. North America AI In Clinical Trials Market Share Forecast by Country (2027-2032) Table 158. Europe AI In Clinical Trials Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Europe AI In Clinical Trials Market Size by Country (2021-2026) & (US$ Million) Table 160. Europe AI In Clinical Trials Market Share by Country (2021-2026) Table 161. Europe AI In Clinical Trials Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Europe AI In Clinical Trials Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific AI In Clinical Trials Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific AI In Clinical Trials Market Size by Country (2021-2026) & (US$ Million) Table 165. Asia-Pacific AI In Clinical Trials Market Share by Country (2021-2026) Table 166. Asia-Pacific AI In Clinical Trials Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Asia-Pacific AI In Clinical Trials Market Share Forecast by Country (2027-2032) Table 168. Latin America AI In Clinical Trials Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America AI In Clinical Trials Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America AI In Clinical Trials Market Share by Country (2021-2026) Table 171. Latin America AI In Clinical Trials Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America AI In Clinical Trials Market Share Forecast by Country (2027-2032) Table 173. Middle East & Africa AI In Clinical Trials Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Middle East & Africa AI In Clinical Trials Market Size by Country (2021-2026) & (US$ Million) Table 175. Middle East & Africa AI In Clinical Trials Market Share by Country (2021-2026) Table 176. Middle East & Africa AI In Clinical Trials Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Middle East & Africa AI In Clinical Trials Market Share Forecast by Country (2027-2032) Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. AI In Clinical Trials Product Image Figure 3. Global AI In Clinical Trials Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global AI In Clinical Trials Market Size (2021-2032) & (US$ Million) Figure 5. Global AI In Clinical Trials Market Share by Region: 2025 VS 2032 Figure 6. Global AI In Clinical Trials Market Share by Region (2021-2032) Figure 7. North America AI In Clinical Trials Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe AI In Clinical Trials Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific AI In Clinical Trials Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America AI In Clinical Trials Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa AI In Clinical Trials Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Software Image Figure 13. Global Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Service Image Figure 15. Global Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global AI In Clinical Trials Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global AI In Clinical Trials Market Share by Type 2025 VS 2032 Figure 18. North America AI In Clinical Trials Market Size Share by Type (2021-2032) Figure 19. Europe AI In Clinical Trials Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific AI In Clinical Trials Market Size Share by Type (2021-2032) Figure 21. Latin America AI In Clinical Trials Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa AI In Clinical Trials Market Size Share by Type (2021-2032) Figure 23. Pharmaceutical and Biotechnology Companies Image Figure 24. Global Pharmaceutical and Biotechnology Companies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Contract Research Organization Image Figure 26. Global Contract Research Organization Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Other Image Figure 28. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global AI In Clinical Trials Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global AI In Clinical Trials Market Share by Application 2025 VS 2032 Figure 31. North America AI In Clinical Trials Market Size Share by Application (2021-2032) Figure 32. Europe AI In Clinical Trials Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific AI In Clinical Trials Market Size Share by Application (2021-2032) Figure 34. Latin America AI In Clinical Trials Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa AI In Clinical Trials Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 AI In Clinical Trials Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America AI In Clinical Trials Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America AI In Clinical Trials Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America AI In Clinical Trials Market Share by Country (2021-2032) Figure 41. Europe AI In Clinical Trials Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe AI In Clinical Trials Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe AI In Clinical Trials Market Share by Country (2021-2032) Figure 44. Asia-Pacific AI In Clinical Trials Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific AI In Clinical Trials Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific AI In Clinical Trials Market Share by Country (2021-2032) Figure 47. Latin America AI In Clinical Trials Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America AI In Clinical Trials Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America AI In Clinical Trials Market Share by Country (2021-2032) Figure 50. Middle East & Africa AI In Clinical Trials Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa AI In Clinical Trials Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa AI In Clinical Trials Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Software
  • Service
Applications
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organization
  • Other
Companies covered
  • Intel
  • The International Business Machines Corporation(IBM)
  • Koninklijke Philips N.V.
  • ConcertAl
  • Saama Technologies LLC
  • Samaa Technologies
  • Owkin Inc.
  • Numerate
  • Neuroute
  • AiCure
  • Ardigen
  • Unlearn Al
  • PathAl
  • Exscentia
  • Aitia Infotech Pvt Ltd.
  • Euretos
  • VeriSIM Life
  • Envisagenics
  • NURITAs
  • BioSymetrics
  • BioAge Labs lInc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global AI In Clinical Trials Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global AI In Clinical Trials Market Size by Region (2021-2032)
  5. 1.4.1 Global AI In Clinical Trials Market Size by Region (2021-2026)
  6. 1.4.2 Global AI In Clinical Trials Market Size by Region (2027-2032)
  7. 1.5 Key Regions AI In Clinical Trials Market Size (2021-2032)
  8. 1.5.1 North America AI In Clinical Trials Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe AI In Clinical Trials Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific AI In Clinical Trials Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America AI In Clinical Trials Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa AI In Clinical Trials Market Size Growth Rate (2021-2032)
2 AI In Clinical Trials Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Software
  3. 2.1.2 Service
  4. 2.2 Global AI In Clinical Trials Market Size by Type
  5. 2.2.1 Global AI In Clinical Trials Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global AI In Clinical Trials Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global AI In Clinical Trials Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global AI In Clinical Trials Market Size by Regions
  9. 2.3.1 North America AI In Clinical Trials Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe AI In Clinical Trials Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific AI In Clinical Trials Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America AI In Clinical Trials Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa AI In Clinical Trials Market Size Breakdown by Type (2021-2026)
3 AI In Clinical Trials Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Pharmaceutical and Biotechnology Companies
  3. 3.1.2 Contract Research Organization
  4. 3.1.3 Other
  5. 3.2 Global AI In Clinical Trials Market Size by Application
  6. 3.2.1 Global AI In Clinical Trials Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global AI In Clinical Trials Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global AI In Clinical Trials Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global AI In Clinical Trials Market Size by Regions
  10. 3.3.1 North America AI In Clinical Trials Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe AI In Clinical Trials Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific AI In Clinical Trials Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America AI In Clinical Trials Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa AI In Clinical Trials Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 AI In Clinical Trials Industry Trends
  2. 4.2 AI In Clinical Trials Industry Drivers
  3. 4.3 AI In Clinical Trials Industry Opportunities and Challenges
  4. 4.4 AI In Clinical Trials Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by AI In Clinical Trials Revenue (2021-2026)
  2. 5.2 Global AI In Clinical Trials Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global AI In Clinical Trials Key Company Headquarters & Area Served
  4. 5.4 Global AI In Clinical Trials Company, Product Type & Application
  5. 5.5 Global AI In Clinical Trials Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global AI In Clinical Trials Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 AI In Clinical Trials Players Market Share by Revenue in 2025
  9. 5.6.3 2025 AI In Clinical Trials Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Intel
  2. 6.1.1 Intel Company Information
  3. 6.1.2 Intel Business Overview
  4. 6.1.3 Intel AI In Clinical Trials Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Intel AI In Clinical Trials Product Portfolio
  6. 6.1.5 Intel Recent Developments
  7. 6.2 The International Business Machines Corporation(IBM)
  8. 6.2.1 The International Business Machines Corporation(IBM) Company Information
  9. 6.2.2 The International Business Machines Corporation(IBM) Business Overview
  10. 6.2.3 The International Business Machines Corporation(IBM) AI In Clinical Trials Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 The International Business Machines Corporation(IBM) AI In Clinical Trials Product Portfolio
  12. 6.2.5 The International Business Machines Corporation(IBM) Recent Developments
  13. 6.3 Koninklijke Philips N.V.
  14. 6.3.1 Koninklijke Philips N.V. Company Information
  15. 6.3.2 Koninklijke Philips N.V. Business Overview
  16. 6.3.3 Koninklijke Philips N.V. AI In Clinical Trials Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Koninklijke Philips N.V. AI In Clinical Trials Product Portfolio
  18. 6.3.5 Koninklijke Philips N.V. Recent Developments
  19. 6.4 ConcertAl
  20. 6.4.1 ConcertAl Company Information
  21. 6.4.2 ConcertAl Business Overview
  22. 6.4.3 ConcertAl AI In Clinical Trials Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 ConcertAl AI In Clinical Trials Product Portfolio
  24. 6.4.5 ConcertAl Recent Developments
  25. 6.5 Saama Technologies LLC
  26. 6.5.1 Saama Technologies LLC Company Information
  27. 6.5.2 Saama Technologies LLC Business Overview
  28. 6.5.3 Saama Technologies LLC AI In Clinical Trials Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Saama Technologies LLC AI In Clinical Trials Product Portfolio
  30. 6.5.5 Saama Technologies LLC Recent Developments
  31. 6.6 Samaa Technologies
  32. 6.6.1 Samaa Technologies Company Information
  33. 6.6.2 Samaa Technologies Business Overview
  34. 6.6.3 Samaa Technologies AI In Clinical Trials Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Samaa Technologies AI In Clinical Trials Product Portfolio
  36. 6.6.5 Samaa Technologies Recent Developments
  37. 6.7 Owkin Inc.
  38. 6.7.1 Owkin Inc. Company Information
  39. 6.7.2 Owkin Inc. Business Overview
  40. 6.7.3 Owkin Inc. AI In Clinical Trials Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Owkin Inc. AI In Clinical Trials Product Portfolio
  42. 6.7.5 Owkin Inc. Recent Developments
  43. 6.8 Numerate
  44. 6.8.1 Numerate Company Information
  45. 6.8.2 Numerate Business Overview
  46. 6.8.3 Numerate AI In Clinical Trials Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Numerate AI In Clinical Trials Product Portfolio
  48. 6.8.5 Numerate Recent Developments
  49. 6.9 Neuroute
  50. 6.9.1 Neuroute Company Information
  51. 6.9.2 Neuroute Business Overview
  52. 6.9.3 Neuroute AI In Clinical Trials Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Neuroute AI In Clinical Trials Product Portfolio
  54. 6.9.5 Neuroute Recent Developments
  55. 6.10 AiCure
  56. 6.10.1 AiCure Company Information
  57. 6.10.2 AiCure Business Overview
  58. 6.10.3 AiCure AI In Clinical Trials Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 AiCure AI In Clinical Trials Product Portfolio
  60. 6.10.5 AiCure Recent Developments
  61. 6.11 Ardigen
  62. 6.11.1 Ardigen Company Information
  63. 6.11.2 Ardigen Business Overview
  64. 6.11.3 Ardigen AI In Clinical Trials Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Ardigen AI In Clinical Trials Product Portfolio
  66. 6.11.5 Ardigen Recent Developments
  67. 6.12 Unlearn Al
  68. 6.12.1 Unlearn Al Company Information
  69. 6.12.2 Unlearn Al Business Overview
  70. 6.12.3 Unlearn Al AI In Clinical Trials Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Unlearn Al AI In Clinical Trials Product Portfolio
  72. 6.12.5 Unlearn Al Recent Developments
  73. 6.13 PathAl
  74. 6.13.1 PathAl Company Information
  75. 6.13.2 PathAl Business Overview
  76. 6.13.3 PathAl AI In Clinical Trials Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 PathAl AI In Clinical Trials Product Portfolio
  78. 6.13.5 PathAl Recent Developments
  79. 6.14 Exscentia
  80. 6.14.1 Exscentia Company Information
  81. 6.14.2 Exscentia Business Overview
  82. 6.14.3 Exscentia AI In Clinical Trials Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Exscentia AI In Clinical Trials Product Portfolio
  84. 6.14.5 Exscentia Recent Developments
  85. 6.15 Aitia Infotech Pvt Ltd.
  86. 6.15.1 Aitia Infotech Pvt Ltd. Company Information
  87. 6.15.2 Aitia Infotech Pvt Ltd. Business Overview
  88. 6.15.3 Aitia Infotech Pvt Ltd. AI In Clinical Trials Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Aitia Infotech Pvt Ltd. AI In Clinical Trials Product Portfolio
  90. 6.15.5 Aitia Infotech Pvt Ltd. Recent Developments
  91. 6.16 Euretos
  92. 6.16.1 Euretos Company Information
  93. 6.16.2 Euretos Business Overview
  94. 6.16.3 Euretos AI In Clinical Trials Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Euretos AI In Clinical Trials Product Portfolio
  96. 6.16.5 Euretos Recent Developments
  97. 6.17 VeriSIM Life
  98. 6.17.1 VeriSIM Life Company Information
  99. 6.17.2 VeriSIM Life Business Overview
  100. 6.17.3 VeriSIM Life AI In Clinical Trials Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 VeriSIM Life AI In Clinical Trials Product Portfolio
  102. 6.17.5 VeriSIM Life Recent Developments
  103. 6.18 Envisagenics
  104. 6.18.1 Envisagenics Company Information
  105. 6.18.2 Envisagenics Business Overview
  106. 6.18.3 Envisagenics AI In Clinical Trials Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Envisagenics AI In Clinical Trials Product Portfolio
  108. 6.18.5 Envisagenics Recent Developments
  109. 6.19 NURITAs
  110. 6.19.1 NURITAs Company Information
  111. 6.19.2 NURITAs Business Overview
  112. 6.19.3 NURITAs AI In Clinical Trials Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 NURITAs AI In Clinical Trials Product Portfolio
  114. 6.19.5 NURITAs Recent Developments
  115. 6.20 BioSymetrics
  116. 6.20.1 BioSymetrics Company Information
  117. 6.20.2 BioSymetrics Business Overview
  118. 6.20.3 BioSymetrics AI In Clinical Trials Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 BioSymetrics AI In Clinical Trials Product Portfolio
  120. 6.20.5 BioSymetrics Recent Developments
  121. 6.21 BioAge Labs lInc
  122. 6.21.1 BioAge Labs lInc Company Information
  123. 6.21.2 BioAge Labs lInc Business Overview
  124. 6.21.3 BioAge Labs lInc AI In Clinical Trials Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 BioAge Labs lInc AI In Clinical Trials Product Portfolio
  126. 6.21.5 BioAge Labs lInc Recent Developments
7 North America
  1. 7.1 North America AI In Clinical Trials Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America AI In Clinical Trials Market Size by Country (2021-2026)
  3. 7.3 North America AI In Clinical Trials Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe AI In Clinical Trials Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe AI In Clinical Trials Market Size by Country (2021-2026)
  3. 8.3 Europe AI In Clinical Trials Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific AI In Clinical Trials Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific AI In Clinical Trials Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific AI In Clinical Trials Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America AI In Clinical Trials Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America AI In Clinical Trials Market Size by Country (2021-2026)
  3. 10.3 South America AI In Clinical Trials Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa AI In Clinical Trials Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa AI In Clinical Trials Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa AI In Clinical Trials Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst